- HK$98.77bn
- HK$98.10bn
- CNY124.25bn
- 73
- 81
- 94
- 98
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | CAS | CAS | CAS | CAS | CAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 90,737 | 101,451 | 114,522 | 122,954 | 124,251 |
Cost of Revenue | |||||
Gross Profit | 32,467 | 31,959 | 39,544 | 44,935 | 50,798 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 83,184 | 95,980 | 105,846 | 114,160 | 113,992 |
Operating Profit | 7,552 | 5,471 | 8,676 | 8,795 | 10,258 |
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 7,162 | 5,064 | 8,499 | 8,752 | 10,203 |
Provision for Income Taxes | |||||
Net Income After Taxes | 5,777 | 4,722 | 7,036 | 7,792 | 9,241 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 5,496 | 4,276 | 6,813 | 8,080 | 9,326 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 5,148 | 4,260 | 6,813 | 8,080 | 9,326 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.691 | 0.733 | 1.31 | 1.79 | 1.95 |
Dividends per Share |